Treatment as prevention works!
Long-term CD4 cell gains on treatment weaker in over-50s
First-line treatment for HIV-2: superior outcomes seen with a boosted protease inhibitor
Rilpivirine (Edurant) approved in United States
'Virtual Hospital' a satisfactory and safe way to deliver care to clinically stable HIV-positive patients
South African women with AIDS conspiracy beliefs half as likely to use condoms
Progress on HIV treatment 'fragile', says MSF report
